Investor Presentaiton

Investor presentation First three months of 2017 Solid position in the diabetes care market across all regions with leading insulin market share Slide 38 Regions Diabetes care value Diabetes care value market composition market share Insulin volume market composition Insulin volume market share 30% 38% North America 58% 71% 29% 52% 63% 37% 12% 10% 41% 43% Region Europe 47% 72% 28% 41% 55% 45% 10% 19% 44% 26% Region AAMEO¹ 54% 76% 24% 25% 43% 57% 2% 49% 47% 21% Region China¹ 52% 69% 31% 16% 46% 54% 62% 1% Region Japan 16% 38% 80% 89% 11% 39% 51% 49% & Korea 23% 4% 27% Region Latin 19% 69% 85% 15% 74% 58% 42% America 5% 7% AAMEO: Africa, Asia, Middle-East and Oceania Insulin 1 IMS only covers part of the channels in Region AAMEO and Region China GLP-1 Source: IMS February, 2017 Monthly MAT volume and value (DKK) figures OAD Novo Nordisk Others Fast-acting Premix Novo Nordisk Others Long-acting novo nordisk

View entire presentation